Performance of the PRIMaCY sudden death risk prediction model for childhood hypertrophic cardiomyopathy: implications for implantable cardioverter-defibrillator decision-making

AIMS: The validated HCM Risk-Kids model provides accurate individualized estimates of sudden cardiac death risk in children with hypertrophic cardiomyopathy (HCM). A second validated model, PRIMaCY, also provides individualized estimates of risk, but its performance and clinical impact has not been...

Descripción completa

Detalles Bibliográficos
Autores principales: Norrish, Gabrielle, Protonotarios, Alexandros, Stec, Maria, Boleti, Olga, Field, Ella, Cervi, Elena, Elliott, Perry M, Kaski, Juan P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666656/
https://www.ncbi.nlm.nih.gov/pubmed/37995093
http://dx.doi.org/10.1093/europace/euad330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666656/
https://www.ncbi.nlm.nih.gov/pubmed/37995093
http://dx.doi.org/10.1093/europace/euad330

Ejemplares similares